| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/31/2006 | CA2119261C Novel sidechain-bearing taxanes and intermediates thereof |
| 01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | WO2006009653A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 01/26/2006 | WO2006008644A1 Antidiabetic compounds |
| 01/26/2006 | WO2005116009B1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |
| 01/26/2006 | WO2005111020A3 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4 |
| 01/26/2006 | WO2005097134A3 Quinazoline based protein kinase inhibitors |
| 01/26/2006 | WO2005085234A3 Bycyclic anthranilamide derivatives useful as insecticides |
| 01/26/2006 | WO2005077922A3 Process for the preparation of substituted triazole compounds |
| 01/26/2006 | WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
| 01/26/2006 | WO2005069981A3 Method of preparation of benzofuran-2-carboxylic acid {(s)-3-methyl-1-[(4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide |
| 01/26/2006 | WO2004096798A3 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020133 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/26/2006 | US20060020016 5-Ethoxy-4-(1-(benzyloxycarbonyl)-2-pyrrolidinylcarbonylamino)-5H-furan-2-one; purification by chromatography, selectively crystallization, or dynamic crystallization; useful for preparing caspase inhibitors |
| 01/26/2006 | US20060020012 Pyrazole derivatives |
| 01/26/2006 | US20060020011 Diseases mediated by tachykinins and for seritonin reuptake transporter protein as reuptake inhibitors |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060020003 Biphenyloxy-acids |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019974 4-Amino-quinazolines |
| 01/26/2006 | US20060019953 Pyridine inhibitors of ERK2 and uses thereof |
| 01/26/2006 | US20060019948 Methylidene-D-xylopyranosyl- and oxo-D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 01/26/2006 | US20060019947 Therapeutic chromone compounds |
| 01/26/2006 | US20060019906 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 01/26/2006 | US20060019831 1-(3-trifluoromethyl)phenyl-3-(N-methyl)carboxamido-2-pyrrolidinone; herbicides; high compatibility with crop plants is desirable; no adverse effect on the chlorophyll synthesis in crop plants; crop protection compositions |
| 01/26/2006 | US20060018846 Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/26/2006 | DE10223908B4 Verfahren zur Herstellung von substituierten Pyridinen A process for the preparation of substituted pyridines |
| 01/26/2006 | CA2579724A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2573210A1 Viral polymerase inhibitors |
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/25/2006 | EP1619183A2 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1, 4-benzodioxane derivatives |
| 01/25/2006 | EP1618105A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| 01/25/2006 | EP1618094A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 01/25/2006 | EP1618093A2 Indazole derivatives as jnk inhibitors |
| 01/25/2006 | EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617841A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 01/25/2006 | EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617807A2 Substituted 1,4-diazepines and uses thereof |
| 01/25/2006 | EP1495040A4 Method for synthesizing beta-l-fluoro-2',3'didehydcytidine (beta-l-fd4c) |
| 01/25/2006 | CN1726211A Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 01/25/2006 | CN1726207A Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/25/2006 | CN1726205A 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1726196A Pyrazine-based tubulin inhibitors |
| 01/25/2006 | CN1726194A Novel compounds |
| 01/25/2006 | CN1724521A New quinazoline hind derivative, medicinal composition containing same and their use |
| 01/25/2006 | CN1238353C Amino acid ester containing azole antifungal agent |
| 01/25/2006 | CN1238347C Heterocyclic derivatives |
| 01/25/2006 | CN1238343C Pyrimidine derivatives and herbicides containing the same |
| 01/24/2006 | US6989452 Anticancer agents |
| 01/24/2006 | US6989449 Containing nitroxide or hydroxylamine moieties; use stabilizing pulp or paper against yellowing and discoloration due to light |
| 01/24/2006 | US6989398 Benzanilides as potassium channel openers |
| 01/24/2006 | US6989397 Iron chelators and uses thereof |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989392 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2205757C Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii) |
| 01/24/2006 | CA2191832C Block oligomers containing 2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 01/19/2006 | WO2006006573A1 Filter and cyanine compound |
| 01/19/2006 | WO2006005915A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2005115981A3 A process for the preparation of 1-(9h-carbazol-4-yloxy)-3-2-(-methoxyphenoxy)-ethyl amino-propan-2-ol |
| 01/19/2006 | WO2005113514A3 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems |
| 01/19/2006 | WO2005097746A3 2-propene-1-ones as hsp 70 inducers |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | WO2005092307A3 Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists |
| 01/19/2006 | WO2005075458A8 Pyrimidine derivatives as orexin receptors antagonists |
| 01/19/2006 | US20060014950 Combining a strong base with a phenyl isonicotinamide in aprotic solvents to form a solutions, then reacting with a cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014827 3-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 01/19/2006 | US20060014817 CCK-1 receptor modulators |
| 01/19/2006 | US20060014796 Epothilone derivatives |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014789 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014785 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014768 Antiproliferative, anticancer, antitumor agents; rheumatism; N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-acetamide; a p15, and/or a protein inducing action, and/or an MEK inhibitory action; side effect reduction |
| 01/19/2006 | US20060014756 Benzimidazoles |
| 01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060013860 Anticancer agents; side effect reduction |
| 01/19/2006 | DE19748440B4 6,7-Difluor-1,2,3,4-tetrahydronaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen, diese enthaltende Flüssigkristallmischungen sowie ferroelektrische Schalt- und/oder Anzeigevorrichtungen 6,7-difluoro-1,2,3,4-tetrahydronaphthalene derivatives and their use in liquid crystalline mixtures, liquid crystal mixtures containing them, as well as ferroelectric switching and / or display devices |
| 01/19/2006 | DE102004031323A1 Substituierte Pyridazincarboxamide und Derivate hiervon And derivatives thereof substituted Pyridazincarboxamide |
| 01/19/2006 | DE102004023332A1 Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung Quinoxalin-2-one derivatives, useful-plant-protecting compositions containing them and processes for their preparation and their use |
| 01/19/2006 | CA2571750A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/18/2006 | EP1616569A1 Medicinal composition |
| 01/18/2006 | EP1615914A2 Cgrp receptor antagonists |
| 01/18/2006 | EP1615909A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 01/18/2006 | EP1615906A1 Compositions useful as inhibitors of protein kinases |
| 01/18/2006 | EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions |
| 01/18/2006 | EP1615899A1 Alpha-substituted carboxylic acids as ppar modulators |
| 01/18/2006 | EP1615894A2 3-azabicyclo 3.2.1 octane derivatives |
| 01/18/2006 | EP1615890A1 Piperidine derivatives as renin inhibitors for the treatment of hypertension |
| 01/18/2006 | EP1615889A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |